News | December 28, 2016

SNMMI Develops USP Recommendations for Compounded Sterile Radiopharmaceuticals

SNMMI Develops USP Recommendations for Compounded Sterile Radiopharmaceuticals

December 28, 2016 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has developed United States Pharmacopeia (USP) recommendations for compounded sterile radiopharmaceuticals. The recommendations aim to address certain common practices in the field of nuclear pharmacy that are not adequately defined by generally accepted practice standards. The society believes there is confusion in the field of nuclear pharmacy, which threatens the availability and the safe usage of radiopharmaceuticals in the United States. The recommendations are a response to these challenges. 

The recommendations were developed by SNMMI's Committee on Radiopharmaceuticals (COR) and approved by SNMMI's Board of Directors. The COR worked with several professional organizations and trade associations in an attempt to rectify the situation. Our efforts to date have met with some success, but have still fallen short of realizing suitable standards that are generally accepted for common practices in nuclear pharmacy. The COR believes that the USP, as the world’s leading organization for the development and maintenance of public standards, can play a critical role in the resolution of these challenges. 

There are three recommendations detailed in a SNMMI white paper: 

1. Establish an expert panel to delineate common practices that are defined as sterile compounding within the practice of nuclear pharmacy.
2. Create a public standard for the preparation, compounding, and dispensing of sterile radiopharmaceuticals with the practice of nuclear pharmacy.
3. Reinstate an expert committee dedicated to all standards for radiopharmaceuticals.

On September 29, SNMMI President Sally Schwarz sent the letter to the USP, where it is currently under consideration. Further details will be provided as they become available.

Access the complete document at http://snmmi.files.cms-plus.com/SNMMI-USP-Recommendations-Final_2016.pdf

Related Content

Medrad Intego PET Infusion System, recall
News | Nuclear Imaging | January 12, 2017
January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source Admini
Mirada Medical, RSNA 2016, XD:PACS, molecular imaging, nuclear imaging
Technology | PACS | January 06, 2017
Mirada Medical showcased its latest XD:PACS (picture archiving and communication system) range of molecular imaging...
SPECT-CT, 3-D printing, University of Wurzburg, Germany, Johannes Tran-Gia, dosimetry calibration

SPECT/CT reconstructions and VOIs used for determination of calibration factors for the adult kidney filled with Lu-177 (A) and the corresponding sphere filled with I-131 (B). Credit: University of Würzburg

News | 3-D Printing | January 06, 2017
In nuclear medicine, the goal is to keep radiation exposure at a minimum, while obtaining quality images. Optimal...
News | Radiopharmaceuticals and Tracers | January 06, 2017
New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of prostate cancer,...
Nuclear cardiology, dose reduction, myocardial perfusion imaging
News | Nuclear Imaging | January 05, 2017
January 5, 2017 — Working in concert, the American Society of Nuclear Cardiology (ASNC), the Intersocietal Accreditat
metastatic colorectal cancer, mCRC, Sirtex, NCCN guidelines, Y-90 microspheres
News | Radiation Therapy | January 03, 2017
Sirtex Medical Limited announced in December that SIR-Spheres Y-90 resin microspheres have been included as a Category...
prostate, CT scan
News | Prostate Cancer | December 22, 2016
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and...
News | Prostate Cancer | December 14, 2016
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on small molecules that...
News | Nuclear Imaging | December 12, 2016
Molecular Targeting Technologies, Inc. (MTTI) announces that response of colorectal cancer to treatment can be detected...
Numa, NumaStatus, radiation dose reporting software, RSNA 2016
News | Radiation Dose Management | December 08, 2016
Numa introduced a new software application at the 2016 Annual Meeting of the Radiological Society of North America (...
Overlay Init